Cargando…
PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma
Ovarian clear cell carcinoma (OCCC) exhibits distinct phenotypes, such as resistance to chemotherapy, poor prognosis and an association with endometriosis. Biomarkers and imaging techniques currently in use are not sufficient for reliable diagnosis of this tumor or prediction of therapeutic response...
Autores principales: | Morikawa, Asuka, Hayashi, Tomoatsu, Shimizu, Naomi, Kobayashi, Mana, Taniue, Kenzui, Takahashi, Akiko, Tachibana, Kota, Saito, Misato, Kawabata, Ayako, Iida, Yasushi, Ueda, Kazu, Saito, Motoaki, Yanaihara, Nozomu, Tanabe, Hiroshi, Yamada, Kyosuke, Takano, Hirokuni, Nureki, Osamu, Okamoto, Aikou, Akiyama, Tetsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880602/ https://www.ncbi.nlm.nih.gov/pubmed/29632642 http://dx.doi.org/10.18632/oncotarget.24555 |
Ejemplares similares
-
Laparoscopic Surgery for Atypical Endometrial Hyperplasia with Awareness Regarding the Possibility of Endometrial Cancer
por: Kamii, Misato, et al.
Publicado: (2022) -
MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma
por: Yanaihara, Nozomu, et al.
Publicado: (2016) -
Feasibility of reduced port surgery applying Higuchi’s transverse incision
por: Ueda, Kazu, et al.
Publicado: (2017) -
MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma
por: Hirata, Yukihiro, et al.
Publicado: (2014) -
MicroRNA-34a/IL-6R pathway as a potential therapeutic target for ovarian high-grade serous carcinoma
por: Yokomizo, Ryo, et al.
Publicado: (2019)